Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This review is published in the PlexusDx Education Hub, our evidence-based library on GLP-1 therapy, weight management protocols, and the genetics behind metabolic results. Browse all Peptides & GLP-1 education
This is independent editorial coverage, not a buying recommendation. PlexusDx has no commercial relationship with Henry Meds, runs no affiliate links, and receives no compensation for this mention.
Full head-to-head: PlexusDx vs Henry Meds →
People looking up the Henry Meds weight loss program usually want three things clarified: what medications are on the menu, what it costs, and how the provider process works. This review walks through each, then names the genetic variable the program does not address. Figures reflect pricing verified July 20, 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What the Henry Meds weight loss program is
Henry Meds combines telehealth with a compounding-pharmacy pathway. After a virtual intake, a licensed provider can prescribe to a retail pharmacy for FDA-approved brand products or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide, with follow-up support afterward. Its current structure is documented on Henry Meds's official website.
The provider and intake process
The flow mirrors most GLP-1 telehealth programs: you complete an intake covering weight, medical history, and current medications; a licensed clinician reviews it and, if you meet the criteria, issues a prescription; the prescription routes to a retail or compounding pharmacy; and telehealth follow-up supports dose titration and side-effect management. Provider type and pharmacy partner can vary within the program.
Reading the price ladder
Henry charges per medication rather than one flat fee, and its lowest advertised figure requires a full year prepaid, so the month-to-month cost runs higher. Here is the ladder, each rate labeled so you know which applies (verified July 20, 2026):
-
Injectable compounded semaglutide, the flagship: $297/month month-to-month. Prepaying lowers it — the 6-month plan is $1,482 ($247/month) and the 12-month plan is $2,364 ($197/month). The advertised “$197/month” is that prepaid-annual rate, not a monthly price.
-
Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier.
-
Oral tirzepatide: dissolving tablets only; no injectable tirzepatide as of July 2026. Sold as a 3-month supply at $1,047 ($891 paid in full), with no published month-to-month rate.
-
Liraglutide (injectable): $179/month month-to-month.
-
Phentermine (oral): $149/month.
There is no membership fee and no visit charge; the evaluation is free and nothing bills until a prescription is written, with medication, supplies, shipping, and care bundled in. Henry's refund policy is not stated, and month-to-month and 6-month plans auto-renew — canceling a multi-month plan early can mean paying out the balance unless a medical reason prevents continuing. Re-confirm figures on Henry Meds's official website.
What the trials show about these compounds
The program's pharmacology comes from the underlying class: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide, which act on appetite, satiety, and gastric emptying. Key trials studied the compounds themselves — STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Populations, endpoints, and individual outcomes vary.
The genetic layer the program does not measure
What a weight loss intake never captures is the inherited biology a GLP-1 drug lands on. FTO shapes fat-mass and obesity risk, MC4R sits at the center of satiety and energy balance, GLP1R encodes the receptor every GLP-1 compound targets, and TCF7L2 ties to glucose regulation and GLP-1 secretion. These pathway-level variants describe your terrain rather than predict a response. PlexusDx pairs its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — with the Precision Peptide Genetic Test, reading 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2. That is test before you invest: know your baseline, then plan with your provider.
Not affiliated: PlexusDx has no affiliation with Henry Meds and no commercial tie to any company reviewed here.
Related reading on PlexusDx: Wegovy Weight Loss, GLP 1 Weight Loss, Tirzepatide Weight Loss, Wegovy For Weight Loss.
Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols or start upstream with the Precision Peptide Genetic Test.
Frequently Asked Questions
How much does the Henry Meds weight loss program cost?
As verified July 20, 2026, injectable compounded semaglutide is $297/month month-to-month, falling to $247 on the 6-month plan or $197 on the 12-month prepaid plan. Oral semaglutide is $249/month with a $179 tier, liraglutide $179/month, and phentermine $149/month. There is no membership fee.
Which weight loss medications does Henry Meds offer?
The menu includes injectable compounded semaglutide, oral sublingual semaglutide, oral tirzepatide as dissolving tablets, injectable liraglutide, and oral phentermine. Henry does not list an injectable tirzepatide as of July 2026. Availability depends on clinical eligibility reviewed at intake, so confirm the current menu on Henry's site.
Does Henry Meds charge a membership or visit fee?
No. Henry charges no membership fee and no per-visit consultation fee; the provider evaluation is free and nothing bills until a prescription is written. Medication, supplies, shipping, and follow-up are bundled into the subscription. Note that multi-month plans auto-renew and early cancellation terms apply.
Does Henry Meds account for my genetics?
No. The program does not evaluate the inherited pathway biology behind a GLP-1 response. The Precision Peptide Genetic Test maps variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 and appetite biology — context for your provider conversation, not a prediction of drug response.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Hers Pricing: Why Discount Codes Don't Change What You Pay
Henry Meds and Zepbound: Tirzepatide Options and Program Model